These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 7643090

  • 21. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
    O'Dell SJ, Weihmuller FB, Marshall JF.
    J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
    [Abstract] [Full Text] [Related]

  • 22. Comparative biochemical pharmacology of central nervous system dopamine D1 and D2 receptors.
    Reader TA, Molina-Holgado E, Dewar KM.
    Mol Neurobiol; 1992 May; 6(4):425-50. PubMed ID: 1285933
    [Abstract] [Full Text] [Related]

  • 23. Modulation of D1-like dopamine receptor function by aldehydic products of lipid peroxidation.
    Shin Y, White BH, Uh M, Sidhu A.
    Brain Res; 2003 Apr 04; 968(1):102-13. PubMed ID: 12644268
    [Abstract] [Full Text] [Related]

  • 24. Characterization of D1 dopamine receptors in the bovine pineal gland with [3H]SCH 23390.
    Simonneaux V, Murrin LC, Ebadi M.
    J Pharmacol Exp Ther; 1990 Apr 04; 253(1):214-20. PubMed ID: 2139469
    [Abstract] [Full Text] [Related]

  • 25. Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats.
    Kiyatkin EA, Rebec GV.
    J Neurosci; 1999 May 01; 19(9):3594-609. PubMed ID: 10212318
    [Abstract] [Full Text] [Related]

  • 26. Induction of G protein-independent agonist high-affinity binding sites of D-1 dopamine receptors by beta-mercaptoethanol.
    Sidhu A, Kimura K, Vachvanichsanong P.
    Biochemistry; 1994 Sep 20; 33(37):11246-53. PubMed ID: 7727376
    [Abstract] [Full Text] [Related]

  • 27. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK, Penney JB, Young AB.
    Neuroscience; 1989 Sep 20; 30(3):767-77. PubMed ID: 2528080
    [Abstract] [Full Text] [Related]

  • 28. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB, Fogel EL, Chen CJ, Congo D, Brown EM, Seeman P.
    Mol Pharmacol; 1988 Jul 20; 34(1):29-36. PubMed ID: 2839763
    [Abstract] [Full Text] [Related]

  • 29. Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.
    O'Neill C, Nolan BJ, Macari A, O'Boyle KM, O'Connor JJ.
    Eur J Neurosci; 2007 Dec 20; 26(12):3421-8. PubMed ID: 18052983
    [Abstract] [Full Text] [Related]

  • 30. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr 20; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G, Norman AB, Hess EJ, Creese I.
    J Neurochem; 1986 Apr 20; 46(4):1180-5. PubMed ID: 3005508
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Characterization of high-affinity dopamine D2 receptors and modulation of affinity states by guanine nucleotides in cholate-solubilized bovine striatal preparations.
    Kazmi SM, Ramwani J, Srivastava LK, Rajakumar G, Ross GM, Cullen M, Mishra RK.
    J Neurochem; 1986 Nov 20; 47(5):1493-502. PubMed ID: 3760872
    [Abstract] [Full Text] [Related]

  • 35. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
    O'Boyle KM, Waddington JL.
    Eur J Pharmacol; 1984 Mar 02; 98(3-4):433-6. PubMed ID: 6144559
    [Abstract] [Full Text] [Related]

  • 36. Dopamine D1 and D2 receptors and their signal system present in coated vesicles prepared from bovine striatal tissue.
    Ozaki N, Moroi K, Kadota T, Suzuki S, Kadota K.
    J Neurochem; 1994 Feb 02; 62(2):582-91. PubMed ID: 8294921
    [Abstract] [Full Text] [Related]

  • 37. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
    De Keyser J, Dierckx R, Vanderheyden P, Ebinger G, Vauquelin G.
    Brain Res; 1988 Mar 08; 443(1-2):77-84. PubMed ID: 2896059
    [Abstract] [Full Text] [Related]

  • 38. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ, McGinty JF.
    J Pharmacol Exp Ther; 1997 May 08; 281(2):972-82. PubMed ID: 9152408
    [Abstract] [Full Text] [Related]

  • 39. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
    Lindgren HS, Ohlin KE, Cenci MA.
    Neuropsychopharmacology; 2009 Nov 08; 34(12):2477-88. PubMed ID: 19606087
    [Abstract] [Full Text] [Related]

  • 40. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH, Kline RH, Geter-Douglass B, Izenwasser S, Witkin JM, Newman AH.
    J Med Chem; 1996 Aug 16; 39(17):3423-8. PubMed ID: 8765528
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.